Part 3: Limited-Stage Hodgkin Lymphoma

Sai Ravi Pingali, MD

Fellow, Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI

Jasleen Randhawa, MD

Fellow, Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI

Timothy S. Fenske, MD

Associate Professor of Medicine, Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI

Question 4

A 21-year-old woman is diagnosed with classical HL and has left cervical and upper mediastinal lymphadenopathy, with all lymph nodes measuring less than 4 cm in size. The patient denies having any night sweats, fevers, or weight loss. Her blood counts are normal and her ESR is 28 mm/hr. Which of the following treatment options would be recommended for the patient?

  •   ABVD (doxorubicin, bleomycin, vinblastine, dacarbazine) therapy x 2 cycles
    followed by 20 Gy of involved-field radiation therapy (IFRT)
  •   ABVD therapy x 2 cycles followed by 30 Gy of IFRT
  •   ABVD therapy x 4 cycles
  •   ABVD therapy x 6 cycles

Updated 07/16/2012 • jdw | Copyright ©2014 Turner White Communications